{
    "2020-12-11": [
        [
            {
                "time": "2021-01-04",
                "original_text": "Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dips",
                        "Broader Markets"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-05",
                "original_text": "Thiel-Backed Developer of Covid-19 Therapy Surges in Debut",
                "features": {
                    "keywords": [
                        "Thiel-Backed",
                        "Covid-19 Therapy",
                        "Surges",
                        "Debut"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-06",
                "original_text": "COVID SCIENCE-Drug combination improves COVID-19 pneumonia outcomes; five genes linked to severe disease",
                "features": {
                    "keywords": [
                        "Drug combination",
                        "Improves",
                        "Pneumonia Outcomes",
                        "Severe Disease"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-07",
                "original_text": "Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine",
                "features": {
                    "keywords": [
                        "ACTT-2 Trial",
                        "Baricitinib",
                        "Hospitalized",
                        "EUA",
                        "Published"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-08",
                "original_text": "Five key severe COVID-19 genes found, suggesting drug targets",
                "features": {
                    "keywords": [
                        "Severe COVID-19 Genes",
                        "Drug Targets"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "genomics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-09",
                "original_text": "Pharma Stock Roundup: FDA Panel's Nod to PFE/BNTX Coronavirus Vaccine, Other Updates",
                "features": {
                    "keywords": [
                        "FDA Panel",
                        "Nod",
                        "PFE/BNTX",
                        "Coronavirus Vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}